Inflarx NV (IFRX) PT Raised to $64 at BMO Capital Following Positive Physician Feedback
Tweet Send to a Friend
BMO Capital analyst Matthew Luchini raised the price target on Inflarx NV (NASDAQ: IFRX) to $64.00 (from $45.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
